Chinese authorities question AstraZeneca staff regarding imported medications
Nucala from GSK emerges victorious in Phase III trial for COPD on Clinical Trials Arena
GSK's medication for asthma, Nucala, achieves success in Phase III trial for COPD - Yahoo Finance
Trial shows that GSK's antibody drug decreases the frequency of COPD attacks - Yahoo Finance
Potential breakthrough in treating chronic lung disease demonstrated by GSK asthma medication - Reported by The Edge Malaysia